Literature DB >> 24493577

Expression and localization of serine protease Htra1 in neuroblastoma: correlation with cellular differentiation grade.

Velia D'Angelo1, Giulia Pecoraro, Paolo Indolfi, Adriana Iannotta, Vittoria Donofrio, Maria Elena Errico, Cristiana Indolfi, Maria Ramaglia, Angela Lombardi, Martina Di Martino, Vincenzo Gigantino, Alfonso Baldi, Michele Caraglia, Antonio De Luca, Fiorina Casale.   

Abstract

Neuroblastoma (NB) is a paediatric tumor that arises from neural crest and shows heterogeneous clinical and biological features. The serine-protease high temperature requirement A1 (HtrA1) has a pivotal role in both cell proliferation and differentiation. Here we report the expression and localization of HtrA1 in NB tumor samples to assess HtrA1 role as a possible new biomarker of cellular differentiation in NB patients. HtrA1 protein expression by Western Blot assay was performed in 60 tissue samples of 50 children with NB and 10 children with ganglioneuroblastoma (GNB). HtrA1 was expressed in 56/60 (93.3 %) samples with different expression levels: low levels in 36/56 samples (64.3 %) and high levels in 20/56 (35.7 %). Higher levels were found in 1, 2 and 4s stages (80 %), whereas 3 and 4 stages (20 %) showed a low expression, with a statistically significant difference (p = 0.003). Among not amplified N-MYC group, 28 (60 %) had low/absent expression of HtrA1: seven with recurrent disease and negative outcome and 21 in continuous complete remission (CCR), whereas all samples with high expression of HtrA1 (17/44) were in CCR (p = 0.03). The immunohistochemical analysis showed localization of HtrA1 in differentiated areas higher than in undifferentiated areas where the protein was absent. Moreover, HtrA1 was highly expressed in all GNB samples. In conclusion, the over-expression of HtrA1 is correlated to cellular differentiation grade and stage of NB at diagnosis. Moreover, HtrA1 could represent a new marker of undifferentiation and biological aggressiveness of NB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24493577     DOI: 10.1007/s11060-014-1387-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992.

Authors:  J G Gurney; J A Ross; D A Wall; W A Bleyer; R K Severson; L L Robison
Journal:  J Pediatr Hematol Oncol       Date:  1997 Sep-Oct       Impact factor: 1.289

2.  Primary structure of a putative serine protease specific for IGF-binding proteins.

Authors:  J Zumbrunn; B Trueb
Journal:  FEBS Lett       Date:  1996-12-02       Impact factor: 4.124

3.  Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.

Authors:  Claudia Spix; Guido Pastore; Risto Sankila; Charles A Stiller; Eva Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2006-09       Impact factor: 9.162

4.  The International Neuroblastoma Pathology Classification (the Shimada system).

Authors:  H Shimada; I M Ambros; L P Dehner; J Hata; V V Joshi; B Roald; D O Stram; R B Gerbing; J N Lukens; K K Matthay; R P Castleberry
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

5.  Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.

Authors:  Viji Shridhar; Ami Sen; Jeremy Chien; Julie Staub; Rajeswari Avula; Steve Kovats; John Lee; Jim Lillie; David I Smith
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

6.  Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.

Authors:  Jeremy Chien; Giovanni Aletti; Alfonso Baldi; Vincenzo Catalano; Pietro Muretto; Gary L Keeney; Kimberly R Kalli; Julie Staub; Michael Ehrmann; William A Cliby; Yean Kit Lee; Keith C Bible; Lynn C Hartmann; Scott H Kaufmann; Viji Shridhar
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

7.  Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma.

Authors:  Paula Lázcoz; Jorge Muñoz; Manuel Nistal; Angel Pestaña; Ignacio J Encío; Javier S Castresana
Journal:  Cancer Genet Cytogenet       Date:  2007-04-01

8.  Analysis of HtrA1 serine protease expression in human lung cancer.

Authors:  Vincenzo Esposito; Mara Campioni; Antonio De Luca; Enrico P Spugnini; Feliciano Baldi; Roberto Cassandro; Alessandro Mancini; Bruno Vincenzi; Angela Groeger; Mario Caputi; Alfonso Baldi
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

9.  Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer.

Authors:  Marissa A Bowden; Lisa A Di Nezza-Cossens; Tom Jobling; Lois A Salamonsen; Guiying Nie
Journal:  Gynecol Oncol       Date:  2006-05-02       Impact factor: 5.482

10.  Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.

Authors:  Y Suzuki; K Takahashi-Niki; T Akagi; T Hashikawa; R Takahashi
Journal:  Cell Death Differ       Date:  2004-02       Impact factor: 15.828

View more
  7 in total

1.  Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes.

Authors:  Tasha Barr; Thomas Girke; Suhas Sureshchandra; Christina Nguyen; Kathleen Grant; Ilhem Messaoudi
Journal:  J Immunol       Date:  2015-11-30       Impact factor: 5.422

2.  Serine protease HtrA1 as an inhibitor on proliferation invasion and migration of gastric cancer.

Authors:  Zhiguo Zhao; Huifang Li; Chuanyi Wang; Wanfang Xu; Junfeng Sun; Wenzhao Zhao
Journal:  Med Oncol       Date:  2015-03-12       Impact factor: 3.064

3.  Characterization of a naturally occurring truncated Dicer.

Authors:  Nicola Mosca; Julia Starega-Roslan; Filomena Castiello; Aniello Russo; Wlodzimierz J Krzyzosiak; Nicoletta Potenza
Journal:  Mol Biol Rep       Date:  2015-04-25       Impact factor: 2.316

4.  The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.

Authors:  Sonia Sanz Muñoz; Hongyun Li; Kalani Ruberu; Qian Chu; Alan Saghatelian; Lezanne Ooi; Brett Garner
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

5.  HtrA1: Its future potential as a novel biomarker for cancer.

Authors:  Emma Altobelli; Daniela Marzioni; Amedeo Lattanzi; Paolo Matteo Angeletti
Journal:  Oncol Rep       Date:  2015-05-28       Impact factor: 3.906

6.  Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.

Authors:  Vito Alessandro Lasorsa; Daniela Formicola; Piero Pignataro; Flora Cimmino; Francesco Maria Calabrese; Jaume Mora; Maria Rosaria Esposito; Marcella Pantile; Carlo Zanon; Marilena De Mariano; Luca Longo; Michael D Hogarty; Carmen de Torres; Gian Paolo Tonini; Achille Iolascon; Mario Capasso
Journal:  Oncotarget       Date:  2016-04-19

7.  HtrA1 as a promising tissue marker in cancer: a meta-analysis.

Authors:  Emma Altobelli; Paolo Matteo Angeletti; Manrico Morroni; Valerio Filippo Profeta
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.